Early Tranexamic Acid Administration after Traumatic Brain Injury Is Associated with Reduced Syndecan-1 and Angiopoietin-2 in Patients with Traumatic Intracranial Hemorrhage

Taylor N. Anderson, Holly E. Hinson, Elizabeth N. Dewey, Elizabeth A. Rick, Martin A. Schreiber, Susan E. Rowell

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Objective: To evaluate the effect of early tranexamic acid (TXA) administration on circulating markers of endotheliopathy. Setting: Twenty trauma centers in the United States and Canada. Participants: Patients with moderate-to-severe traumatic brain injury (TBI) (MS-TBI) and intracranial hemorrhage who were not in shock (systolic blood pressure ≥90 mm Hg). Design: TXA (2 g) or placebo administered prior to hospital arrival, less than 2 hours postinjury. Blood samples and head computed tomographic scan collected upon arrival. Plasma markers measured using Luminex analyte platform. Differences in median marker levels evaluated using t tests performed on log-transformed variables. Comparison groups were TXA versus placebo and less than 45 minutes versus 45 minutes or more from time of injury to treatment administration. Main Measures: Plasma levels of angiopoietin-1, angiopoietin-2, syndecan-1, thrombomodulin, thrombospondin-2, intercellular adhesion molecule 1, vascular adhesion molecule 1. Results: Demographics and Injury Severity Score were similar between the placebo (n = 129) and TXA (n = 158) groups. Levels of syndecan-1 were lower in the TXA group (median [interquartile range or IQR] = 254.6 pg/mL [200.7-322.0] vs 272.4 pg/mL [219.7-373.1], P =.05. Patients who received TXA less than 45 minutes postinjury had significantly lower levels of angiopoietin-2 (median [IQR] = 144.3 pg/mL [94.0-174.3] vs 154.6 pg/mL [110.4-209.8], P =.05). No differences were observed in remaining markers. Conclusions: TXA may inhibit early upregulation of syndecan-1 and angiopoietin-2 in patients with MS-TBI, suggesting attenuation of protease-mediated vascular glycocalyx breakdown. The findings of this exploratory analysis should be considered preliminary and require confirmation in future studies.

    Original languageEnglish (US)
    Pages (from-to)317-323
    Number of pages7
    JournalJournal of Head Trauma Rehabilitation
    Volume35
    Issue number5
    DOIs
    StatePublished - Sep 1 2020

    Keywords

    • angiopoietin-2
    • brain injuries
    • cell adhesion molecules
    • craniocerebral trauma
    • endothelium
    • extracellular matrix proteins
    • glycocalyx
    • intracranial hemorrhages
    • syndecan-1
    • tranexamic acid
    • traumatic

    ASJC Scopus subject areas

    • Physical Therapy, Sports Therapy and Rehabilitation
    • Rehabilitation
    • Clinical Neurology

    Fingerprint

    Dive into the research topics of 'Early Tranexamic Acid Administration after Traumatic Brain Injury Is Associated with Reduced Syndecan-1 and Angiopoietin-2 in Patients with Traumatic Intracranial Hemorrhage'. Together they form a unique fingerprint.

    Cite this